Loading provider…
Loading provider…
Rheumatology Physician in Dayton, OH
NPI: 1255390233Primary Practice Location
MIAMI VALLEY HOSPITAL
1 Wyoming St, Dayton, OH
Primary Employer
Mvhe Inc
premierhealth.com
HQ Phone
Get DO Sanford's Phone NumberMobile
Get DO Sanford's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 182 | 410 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 117 | 177 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 105 | 263 |
| 4 | J0897Injection, denosumab, 1 mg | 89 | 8,820 |
| 5 | J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | 450 |
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Rituximab, DRUG: Belimumab, DRUG: Rituximab-placebo, DRUG: Standard therapy (Including Immunosuppressants), DRUG: Standard therapy (Excluding Immunosuppressants), DRUG: Steroid Taper
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)